Offering money-saving options on BELVIQ and BELVIQ XR, the Savings Card* is available to people with commercial insurance and those who pay cash for their prescriptions.
Receive up to $160 off your out-of-pocket costs, after you pay $30**
Receive up to $160 off your out-of-pocket costs, after you pay $40**
Receive up to $195
off your out-of-pocket costs**
*Savings Card is not available to patients who are eligible for state or federal health care programs. However, Medicare Part D and TRICARE beneficiaries whose coverage does not include BELVIQ® or BELVIQ XR® may use this card. See complete Restrictions and Conditions of Use.
**On average savings card users with commercial coverge pay ≤$66.00 and those without commercial coverage or who pay cash, or who have Medicare Part D or TRICARE whose coverage does not pay for BELVIQ or BELVIQ XR pay an average of ≤$97.00 per month, based upon McKesson cost coverage data.
Call 1-866-61-EISAI (1-866-613-4724) or click here.
Eisai is committed to supporting patient access by helping with your reimbursement questions. With this in mind, the reimbursement site for BELVIQ and BELVIQ XR has been designed to provide patients with information related to coverage for BELVIQ or BELVIQ XR. Please click here to visit the reimbursement site and learn more about patient assistance or resources.
If you do not think you can afford your medication, financial assistance may be available for eligible patients. Click here for more information.
BELVIQ/BELVIQ XR is a FDA-approved prescription weight-loss medication that, when used with diet and exercise, can help some adults (body mass index [BMI] ≥27 kg/m2) living with extra weight, with a weight-related medical problem, or adults living with obesity (BMI ≥30 kg/m2), lose weight and keep it off. It is not known if BELVIQ/BELVIQ XR when taken with other prescription, over-the-counter, or herbal weight-loss products is safe and effective. It is not known if BELVIQ/BELVIQ XR changes your risk of heart problems, stroke, or death due to heart problems or stroke.
BELVIQ®/BELVIQ XR® is a federally controlled substance (CIV) because it may be abused or lead to drug dependence.
For more information about BELVIQ®/BELVIQ XR® talk to your Healthcare Provider and see the full Product Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or